USPTO issued Patent US12594377B2 to Tandem Diabetes Care Switzerland Sàrl for a wearable insulin pump system with microdosing capabilities. The patent covers a patch-style pump design with a reusable pump body and disposable cap containing the microdosing mechanism, applicator for cannula insertion, and adhesive pad application. The 18 claims span the device architecture, microdosing system, and methods for delivering precise medication doses.

For competitors in the insulin pump and diabetes device market, this patent establishes intellectual property protection around Tandem's microdose delivery technology. Companies developing similar wearable insulin delivery systems should review the patent claims for potential infringement risks and consider designing around the protected elements. Healthcare providers and patients are unlikely to see immediate impacts, though this may influence future product availability and pricing dynamics in the insulin pump market.